LIFEVANTAGE CORP Operating Expenses
LIFEVANTAGE CORP (LFVN) reported Operating Expenses of $135.51 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-27
- LIFEVANTAGE CORP operating expenses for the quarter ending 2026-06-30 was $31.38M, a 25.12% decline year-over-year.
- LIFEVANTAGE CORP operating expenses for the quarter ending 2026-03-31 was $32.87M, a 24.05% decline year-over-year.
- LIFEVANTAGE CORP operating expenses for the quarter ending 2025-12-31 was $35.72M, a 30.15% decline year-over-year.
- LIFEVANTAGE CORP operating expenses for the quarter ending 2025-09-30 was $35.55M, a 1.12% increase year-over-year.
- LIFEVANTAGE CORP operating expenses for fiscal 2026 was $135.51M, a 20.97% decline from fiscal 2025.
- LIFEVANTAGE CORP operating expenses for fiscal 2025 was $171.47M, a 11.06% increase from fiscal 2024.
- LIFEVANTAGE CORP operating expenses for fiscal 2024 was $154.39M, a 6.85% decline from fiscal 2023.
- LIFEVANTAGE CORP operating expenses for fiscal 2023 was $165.75M, a 3.15% increase from fiscal 2022.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $31.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $64.24M derived: sum of 2 quarters · filed 2026-08-27 | $99.96M derived: sum of 3 quarters · filed 2026-08-27 | $135.51M 10-K · filed 2026-08-27 | ||||
| 2026-03-31 | $32.87M 10-Q · filed 2026-05-06 | $68.59M derived: sum of 2 quarters · filed 2026-05-06 | $104.14M 10-Q · filed 2026-05-06 | $146.04M derived: sum of 4 quarters · filed 2026-08-27 | ||||
| 2025-12-31 | $35.72M 10-Q · filed 2026-02-04 | $71.27M 10-Q · filed 2026-02-04 | $113.17M derived: sum of 3 quarters · filed 2026-08-27 | $156.44M derived: sum of 4 quarters · filed 2026-08-27 | ||||
| 2025-09-30 | $35.55M 10-Q · filed 2025-11-04 | $77.45M derived: sum of 2 quarters · filed 2026-08-27 | $120.72M derived: sum of 3 quarters · filed 2026-08-27 | $171.86M derived: sum of 4 quarters · filed 2026-08-27 | ||||
| 2025-06-30 | $41.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $85.17M derived: sum of 2 quarters · filed 2026-08-27 | $136.31M derived: sum of 3 quarters · filed 2026-08-27 | $171.47M 10-K · filed 2026-08-27 | ||||
| 2025-03-31 | $43.27M 10-Q · filed 2026-05-06 | $94.41M derived: sum of 2 quarters · filed 2026-05-06 | $129.57M 10-Q · filed 2026-05-06 | $165.56M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $51.14M 10-Q · filed 2026-02-04 | $86.29M 10-Q · filed 2026-02-04 | $122.29M derived: sum of 3 quarters · filed 2026-02-04 | $158.43M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-09-30 | $35.15M 10-Q · filed 2025-11-04 | $71.15M derived: sum of 2 quarters · filed 2025-11-04 | $107.29M derived: sum of 3 quarters · filed 2025-11-04 | $149.11M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | $72.14M derived: sum of 2 quarters · filed 2025-09-04 | $113.96M derived: sum of 3 quarters · filed 2025-09-04 | $154.39M 10-K · filed 2025-09-04 | ||||
| 2024-03-31 | $36.14M 10-Q · filed 2025-05-06 | $77.96M derived: sum of 2 quarters · filed 2025-05-06 | $118.39M 10-Q · filed 2025-05-06 | $158.94M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $41.82M 10-Q · filed 2025-02-05 | $82.25M 10-Q · filed 2025-02-05 | $122.80M derived: sum of 3 quarters · filed 2025-02-05 | $164.33M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-09-30 | $40.44M 10-Q · filed 2024-10-29 | $80.98M derived: sum of 2 quarters · filed 2024-10-29 | $122.51M derived: sum of 3 quarters · filed 2024-10-29 | $165.64M derived: sum of 4 quarters · filed 2024-10-29 | ||||
| 2023-06-30 | $40.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $82.07M derived: sum of 2 quarters · filed 2024-08-28 | $125.21M derived: sum of 3 quarters · filed 2024-08-28 | $165.75M 10-K · filed 2024-08-28 | ||||
| 2023-03-31 | $41.52M 10-Q · filed 2024-05-02 | $84.66M derived: sum of 2 quarters · filed 2024-05-02 | $125.20M 10-Q · filed 2024-05-02 | $165.32M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $43.14M 10-Q · filed 2024-01-30 | $83.68M 10-Q · filed 2024-01-30 | $123.79M derived: sum of 3 quarters · filed 2024-01-30 | $162.31M derived: sum of 4 quarters · filed 2024-01-30 | ||||
| 2022-09-30 | $40.54M 10-Q · filed 2023-11-09 | $80.66M derived: sum of 2 quarters · filed 2023-11-09 | $119.18M derived: sum of 3 quarters · filed 2023-11-09 | $162.05M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $40.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-28 | $78.64M derived: sum of 2 quarters · filed 2023-08-28 | $121.51M derived: sum of 3 quarters · filed 2023-08-28 | $160.69M 10-K · filed 2023-08-28 | ||||
| 2022-03-31 | $38.52M 10-Q · filed 2023-05-04 | $81.39M derived: sum of 2 quarters · filed 2023-05-04 | $120.57M 10-Q · filed 2023-05-04 | $158.99M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $42.87M 10-Q · filed 2023-02-02 | $82.05M 10-Q · filed 2023-02-02 | $120.46M derived: sum of 3 quarters · filed 2023-02-02 | $161.13M derived: sum of 4 quarters · filed 2023-02-02 | ||||
| 2021-09-30 | $39.18M 10-Q · filed 2022-11-02 | $77.59M derived: sum of 2 quarters · filed 2022-11-02 | $118.26M derived: sum of 3 quarters · filed 2022-11-02 | $161.63M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $38.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $79.08M derived: sum of 2 quarters · filed 2022-08-23 | $122.45M derived: sum of 3 quarters · filed 2022-08-23 | $164.38M 10-K · filed 2022-08-23 | ||||
| 2021-03-31 | $40.66M 10-Q · filed 2022-05-03 | $84.03M derived: sum of 2 quarters · filed 2022-05-03 | $125.97M 10-Q · filed 2022-05-03 | $169.68M derived: sum of 4 quarters · filed 2022-08-23 | ||||
| 2020-12-31 | $43.37M 10-Q · filed 2022-02-01 | $85.30M 10-Q · filed 2022-02-01 | $129.01M derived: sum of 3 quarters · filed 2022-08-23 | $172.96M derived: sum of 4 quarters · filed 2022-08-23 | ||||
| 2020-09-30 | $41.93M 10-Q · filed 2021-11-04 | $85.64M derived: sum of 2 quarters · filed 2022-08-23 | $129.59M derived: sum of 3 quarters · filed 2022-08-23 | $176.96M derived: sum of 4 quarters · filed 2022-08-23 | ||||
| 2020-06-30 | $43.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $87.66M derived: sum of 2 quarters · filed 2022-08-23 | $135.03M derived: sum of 3 quarters · filed 2022-08-23 | $179.49M 10-K · filed 2022-08-23 | ||||
| 2020-03-31 | $43.95M 10-Q · filed 2021-04-29 | $91.31M derived: sum of 2 quarters · filed 2021-04-29 | $135.78M 10-Q · filed 2021-04-29 | $176.57M derived: sum of 4 quarters · filed 2021-08-19 | ||||
| 2019-12-31 | $47.37M 10-Q · filed 2021-02-02 | $91.83M 10-Q · filed 2021-02-02 | $132.62M derived: sum of 3 quarters · filed 2021-08-19 | $177.12M derived: sum of 4 quarters · filed 2021-08-19 | ||||
| 2019-09-30 | $44.46M 10-Q · filed 2020-11-03 | $85.25M derived: sum of 2 quarters · filed 2021-08-19 | $129.75M derived: sum of 3 quarters · filed 2021-08-19 | $177.54M derived: sum of 4 quarters · filed 2021-08-19 | ||||
| 2019-06-30 | $40.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-19 | $85.29M derived: sum of 2 quarters · filed 2021-08-19 | $133.09M derived: sum of 3 quarters · filed 2021-08-19 | $178.17M 10-K · filed 2021-08-19 | ||||
| 2019-03-31 | $44.50M 10-Q · filed 2020-05-05 | $92.29M derived: sum of 2 quarters · filed 2020-05-05 | $137.38M 10-Q · filed 2020-05-05 | $179.04M derived: sum of 4 quarters · filed 2020-08-18 | ||||
| 2018-12-31 | $47.79M 10-Q · filed 2020-01-28 | $92.88M 10-Q · filed 2020-01-28 | $134.54M derived: sum of 3 quarters · filed 2020-08-18 | $173.88M derived: sum of 4 quarters · filed 2020-08-18 | ||||
| 2018-09-30 | $45.09M 10-Q · filed 2019-10-30 | $86.75M derived: sum of 2 quarters · filed 2020-08-18 | $126.09M derived: sum of 3 quarters · filed 2020-08-18 | $164.13M derived: sum of 4 quarters · filed 2020-08-18 | ||||
| 2018-06-30 | $41.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-18 | $81.01M derived: sum of 2 quarters · filed 2020-08-18 | $119.04M derived: sum of 3 quarters · filed 2020-08-18 | $158.03M 10-K · filed 2020-08-18 | ||||
| 2018-03-31 | $39.34M 10-Q · filed 2019-05-01 | $77.38M derived: sum of 2 quarters · filed 2019-05-01 | $116.37M 10-Q · filed 2019-05-01 | $156.58M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-12-31 | $38.04M 10-Q · filed 2019-02-04 | $77.03M 10-Q · filed 2019-02-04 | $117.24M derived: sum of 3 quarters · filed 2019-08-14 | $153.79M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-09-30 | $38.99M 10-Q · filed 2018-11-01 | $79.20M derived: sum of 2 quarters · filed 2019-08-14 | $115.75M derived: sum of 3 quarters · filed 2019-08-14 | $156.50M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-06-30 | $40.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-14 | $76.76M derived: sum of 2 quarters · filed 2019-08-14 | $117.51M derived: sum of 3 quarters · filed 2019-08-14 | $161.58M 10-K · filed 2019-08-14 | ||||
| 2017-03-31 | $36.55M 10-Q · filed 2018-05-09 | $77.30M derived: sum of 2 quarters · filed 2018-05-09 | $121.37M 10-Q · filed 2018-05-09 | $160.93M derived: sum of 4 quarters · filed 2018-08-15 | ||||
| 2016-12-31 | $40.75M 10-Q · filed 2018-02-07 | $84.82M 10-Q · filed 2018-02-07 | $124.38M derived: sum of 3 quarters · filed 2018-08-15 | $167.19M derived: sum of 4 quarters · filed 2018-08-15 | ||||
| 2016-09-30 | $44.08M 10-Q · filed 2017-11-08 | $83.63M derived: sum of 2 quarters · filed 2018-08-15 | $126.44M derived: sum of 3 quarters · filed 2018-08-15 | $167.56M derived: sum of 4 quarters · filed 2018-08-15 | ||||
| 2016-06-30 | $39.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-15 | $82.37M derived: sum of 2 quarters · filed 2018-08-15 | $123.49M derived: sum of 3 quarters · filed 2018-08-15 | $159.19M 10-K · filed 2018-08-15 | ||||
| 2016-03-31 | $42.81M 10-Q · filed 2017-05-10 | $83.94M derived: sum of 2 quarters · filed 2017-05-10 | $119.64M 10-Q · filed 2017-05-10 | $156.09M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-12-31 | $41.12M 10-Q · filed 2017-02-08 | $76.83M 10-Q · filed 2017-02-08 | $113.28M derived: sum of 3 quarters · filed 2017-09-07 | $149.39M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-09-30 | $35.71M 10-Q · filed 2016-12-12 | $72.16M derived: sum of 2 quarters · filed 2017-09-07 | $108.27M derived: sum of 3 quarters · filed 2017-09-07 | $145.94M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-06-30 | $36.45M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-09-07 | $72.57M derived: sum of 2 quarters · filed 2017-09-07 | $110.24M derived: sum of 3 quarters · filed 2017-09-07 | $148.43M 10-K · filed 2017-09-07 | ||||
| 2015-03-31 | $36.12M 10-Q/A · filed 2016-07-19 | $73.79M derived: sum of 2 quarters · filed 2016-07-19 | $111.98M 10-Q/A · filed 2016-07-19 | $154.29M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-12-31 | $37.67M 10-Q · filed 2016-02-09 | $75.86M 10-Q · filed 2016-02-09 | $118.17M derived: sum of 3 quarters · filed 2016-12-12 | $160.31M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-09-30 | $38.19M 10-Q · filed 2015-11-04 | $80.50M derived: sum of 2 quarters · filed 2016-12-12 | $122.64M derived: sum of 3 quarters · filed 2016-12-12 | $161.07M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-06-30 | $42.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $84.45M derived: sum of 2 quarters · filed 2016-12-12 | $122.88M derived: sum of 3 quarters · filed 2016-12-12 | $161.33M 10-K · filed 2016-12-12 | ||||
| 2014-03-31 | $42.14M 10-Q · filed 2015-05-06 | $80.57M derived: sum of 2 quarters · filed 2015-05-06 | $119.02M 10-Q · filed 2015-05-06 | $162.99M derived: sum of 4 quarters · filed 2015-09-01 | ||||
| 2013-12-31 | $38.43M 10-Q · filed 2015-02-04 | $76.88M 10-Q · filed 2015-02-04 | $120.86M derived: sum of 3 quarters · filed 2015-09-01 | $160.42M derived: sum of 4 quarters · filed 2015-09-01 | ||||
| 2013-09-30 | $38.45M 10-Q · filed 2014-11-06 | $82.43M derived: sum of 2 quarters · filed 2015-09-01 | $121.99M derived: sum of 3 quarters · filed 2015-09-01 | $160.26M derived: sum of 4 quarters · filed 2015-09-01 | ||||
| 2013-06-30 | $43.98M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-01 | $83.54M derived: sum of 2 quarters · filed 2015-09-01 | $121.81M derived: sum of 3 quarters · filed 2015-09-01 | $159.47M 10-K · filed 2015-09-01 | ||||
| 2013-03-31 | $39.56M 10-Q · filed 2014-05-06 | $77.83M derived: sum of 2 quarters · filed 2014-05-06 | $115.49M 10-Q · filed 2014-05-06 | $146.82M derived: sum of 4 quarters · filed 2014-09-10 | ||||
| 2012-12-31 | $38.27M 10-Q · filed 2014-02-06 | $76.47M 10-Q · filed 2014-02-06 | $107.26M derived: sum of 3 quarters · filed 2014-09-10 | $132.07M derived: sum of 4 quarters · filed 2014-09-10 | ||||
| 2012-09-30 | $38.15M 10-Q · filed 2013-11-07 | $68.98M derived: sum of 2 quarters · filed 2014-09-10 | $93.80M derived: sum of 3 quarters · filed 2014-09-10 | $111.12M derived: sum of 4 quarters · filed 2014-09-10 | ||||
| 2012-06-30 | $30.84M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-10 | $55.65M derived: sum of 2 quarters · filed 2014-09-10 | $72.98M derived: sum of 3 quarters · filed 2014-09-10 | $86.67M 10-K · filed 2014-09-10 | $86.67M 10-K · filed 2012-09-10 | |||
| 2012-03-31 | $24.82M 10-Q · filed 2013-05-09 | $24.82M 10-Q · filed 2012-05-15 | $42.14M derived: sum of 2 quarters · filed 2013-05-09 | $55.84M 10-Q · filed 2013-05-09 | $55.84M 10-Q · filed 2012-05-15 | $66.79M derived: sum of 4 quarters · filed 2013-09-12 | ||
| 2011-12-31 | $17.32M 10-Q · filed 2013-02-07 | $17.32M 10-Q · filed 2012-02-14 | $31.02M 10-Q · filed 2013-02-07 | $31.02M 10-Q · filed 2012-02-14 | $41.98M derived: sum of 3 quarters · filed 2013-09-12 | $49.58M derived: sum of 4 quarters · filed 2013-09-12 | ||
| 2011-09-30 | $13.70M 10-Q · filed 2012-11-08 | $13.70M 10-Q · filed 2011-11-14 | $24.66M derived: sum of 2 quarters · filed 2013-09-12 | $32.26M derived: sum of 3 quarters · filed 2013-09-12 | $37.92M derived: sum of 4 quarters · filed 2013-09-12 | |||
| 2011-06-30 | $10.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-12 | $18.56M derived: sum of 2 quarters · filed 2013-09-12 | $24.22M derived: sum of 3 quarters · filed 2013-09-12 | $29.30M 10-K · filed 2013-09-12 | $29.30M 10-K · filed 2012-09-10 | |||
| 2011-03-31 | $7.60M 10-Q · filed 2012-05-15 | $13.26M derived: sum of 2 quarters · filed 2012-05-15 | $18.34M 10-Q · filed 2012-05-15 | |||||
| 2010-12-31 | $5.66M 10-Q · filed 2012-02-14 | $10.74M 10-Q · filed 2012-02-14 | ||||||
| 2010-09-30 | $5.08M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |